BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25559213)

  • 1. Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.
    Paterni I; Bertini S; Granchi C; Tuccinardi T; Macchia M; Martinelli A; Caligiuri I; Toffoli G; Rizzolio F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Minutolo F
    J Med Chem; 2015 Feb; 58(3):1184-94. PubMed ID: 25559213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Ketoximes as Estrogen Receptor β Selective Agonists.
    Granchi C; Lapillo M; Spena CR; Rizzolio F; Tuccinardi T; Martin TA; Carlson KE; Katzenellenbogen JA; Minutolo F
    ChemMedChem; 2016 Aug; 11(16):1752-61. PubMed ID: 27135651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
    Yang C; Edsall R; Harris HA; Zhang X; Manas ES; Mewshaw RE
    Bioorg Med Chem; 2004 May; 12(10):2553-70. PubMed ID: 15110838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
    Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
    Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic significance of estrogen receptor β agonists in gliomas.
    Sareddy GR; Nair BC; Gonugunta VK; Zhang QG; Brenner A; Brann DW; Tekmal RR; Vadlamudi RK
    Mol Cancer Ther; 2012 May; 11(5):1174-82. PubMed ID: 22442308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells.
    Granchi C; Qian Y; Lee HY; Paterni I; Pasero C; Iegre J; Carlson KE; Tuccinardi T; Chen X; Katzenellenbogen JA; Hergenrother PJ; Minutolo F
    ChemMedChem; 2015 Nov; 10(11):1892-900. PubMed ID: 26332543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of iodocarborane-containing ligands with high affinity and selectivity toward ERβ.
    Ohta K; Ogawa T; Endo Y
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4030-4033. PubMed ID: 28778470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
    Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
    Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel VEGFR-2 inhibitors. Part II: biphenyl urea incorporated with salicylaldoxime.
    Gao H; Su P; Shi Y; Shen X; Zhang Y; Dong J; Zhang J
    Eur J Med Chem; 2015 Jan; 90():232-40. PubMed ID: 25461323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile synthesis and biological evaluation of novel symmetrical biphenyls as antitumor agents.
    Zhang J; Zhang Y; Pan X; Wang C; Hu Z; Wang S; He L
    Med Chem; 2012 Mar; 8(2):145-50. PubMed ID: 22385184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.
    Cincinelli R; Musso L; Giannini G; Zuco V; De Cesare M; Zunino F; Dallavalle S
    Eur J Med Chem; 2014 May; 79():251-9. PubMed ID: 24742384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New naphthoquinone derivatives against glioma cells.
    Redaelli M; Mucignat-Caretta C; Isse AA; Gennaro A; Pezzani R; Pasquale R; Pavan V; Crisma M; Ribaudo G; Zagotto G
    Eur J Med Chem; 2015; 96():458-66. PubMed ID: 25916907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).
    Sampathi Perera KLI; Hanson AM; Lindeman S; Imhoff A; Lu X; Sem DS; Donaldson WA
    Eur J Med Chem; 2018 Sep; 157():791-804. PubMed ID: 30144697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
    Wang R; Zhang X; Song H; Zhou S; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
    Peng X; Hu Z; Zhang J; Ning W; Zhang S; Dong C; Shi X; Zhou HB
    Chem Commun (Camb); 2019 Dec; 55(97):14570-14573. PubMed ID: 31660550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.
    Bertini S; De Cupertinis A; Granchi C; Bargagli B; Tuccinardi T; Martinelli A; Macchia M; Gunther JR; Carlson KE; Katzenellenbogen JA; Minutolo F
    Eur J Med Chem; 2011 Jun; 46(6):2453-62. PubMed ID: 21481497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
    Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
    Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.